Stone clearance · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers may leads to higher stone clearance compared with standard therapy (low certainty).
1 finding from 1 review
Stone expulsion time · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Pain episodes · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Dose of diclofenac (mg) · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Hospital admissions · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in hospitalisation compared with placebo (moderate certainty).
1 finding from 1 review
Surgical intervention · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in surgical intervention compared with placebo (high certainty).
1 finding from 1 review
Major adverse events · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in major adverse events compared with standard therapy (low certainty).
1 finding from 1 review
Stone expulsion time · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Pain episodes · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Dose of diclofenac · adult patients presenting with symptoms of ureteral stone disease
1 finding from 1 review
Hospital admissions · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to lower hospitalisation compared with standard therapy (moderate certainty).
1 finding from 1 review
Surgical intervention · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in surgical intervention compared with standard therapy (low certainty).
1 finding from 1 review
Stone clearance · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to higher stone clearance compared with placebo (moderate certainty).
1 finding from 1 review
Major adverse events · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to higher major adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Stone‐free rate
Alpha‐blockers may leads to higher stone‐free rate compared with placebo with/without analgesics (low certainty).
1 finding from 1 review
Serious adverse events or complications of treatment
1 finding from 1 review
Secondary procedures for residual fragments
It is very uncertain whether alpha‐blockers changes secondary procedures for residual fragments compared with placebo with/without analgesics (very low certainty).
1 finding from 1 review
Hospital stay — not reported
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Global Impressions scale change item (CGI‐I or similar): no. of responders (acute phase) · adults (aged 18‐85)
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Dropouts due to adverse events · adults (aged 18‐85)
Comparison 1: Alpha‐blockers showed no clear difference in treatment tolerability, as measured by Dropouts due to adverse… compared with placebo (moderate certainty).
1 finding from 1 review